Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine
- 31 May 2010
- journal article
- research article
- Published by Elsevier BV in Transplant Immunology
- Vol. 23 (1-2), 53-58
- https://doi.org/10.1016/j.trim.2010.04.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Immunoregulatory functions of mTOR inhibitionNature Reviews Immunology, 2009
- mTOR, Cancer and TransplantationAmerican Journal of Transplantation, 2008
- Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycinTransplant International, 2008
- Development of De Novo Cancer in p53 Knock-Out Mice is Dependent on the Type of Long-Term Immunosuppression UsedTransplantation, 2006
- Rapamycin and tumor growth: mechanisms behind its anticancer activityTransplantation Reviews, 2005
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorNature Medicine, 2002
- IMMUNOPHARMACOLOGY OF RAPAMYCINAnnual Review of Immunology, 1996
- EVIDENCE THAT RAPAMYCIN INHIBITS INTERLEUKIN-12-INDUCED PROLIFERATION OF ACTIVATED T LYMPHOCYTESTransplantation, 1994
- Inhibition of Human B Lymphocyte Cell Cycle Progression and Differentiation by RapamycinCellular Immunology, 1994
- Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycleJournal of Cellular Physiology, 1993